Samy Allam

Manager Group Controlling, M&a And Business Development at R-Biopharm AG

Samy Allam is currently the Interim CFO at AusDiagnostics and also handles Post Merger Integration Finance. Prior to this role, Samy was Manager Group Controlling, M&A, and Business Development at R-Biopharm AG. With experience as Head Of Controlling at LY Holding GmbH, Financial Controller at a production company, and Group Controller at ALD Vacuum Technologies GmbH, Samy has a strong background in finance and controlling. Previous roles at Vacuumschmelze GmbH & Co. KG and ArvinMeritor have provided Samy with experience in subsidiary controlling and financial planning in industries such as automotive and industrial-use magnetic materials. Samy holds a Diplom Betriebswirt (FH) and B. A. International Finance and Law from Frankfurt University of Applied Sciences.

Links

Peers

View in org chart

Timeline

  • Manager Group Controlling, M&a And Business Development

    April, 2021 - present

A panel showing how The Org can help with contacting the right person.